Molecule Details
| InChIKey | IBIQLEWQPHHHEE-UHFFFAOYSA-N |
|---|---|
| Compound Name | 5-(4-{3-[1,2-Dihydroxy-2-(4-nitro-phenyl)-ethyl]-thioureido}-benzenesulfonylamino)-[1,3,4]thiadiazole-2-sulfonic acid amide |
| Canonical SMILES | NS(=O)(=O)c1nnc(NS(=O)(=O)c2ccc(N/C(S)=N/C(O)C(O)c3ccc([N+](=O)[O-])cc3)cc2)s1 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 8.85 |
| Source | ChEMBL;TTD_MultiTarget |
2D Structure
Activity Profile